101 results
8-K
EX-99.1
RVMD
Revolution Medicines Inc
8 May 24
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
4:05pm
-5552.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation
S-3ASR
RVMD
Revolution Medicines Inc
4 Mar 24
Automatic shelf registration
5:23pm
authorized for use in connection with this offering may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act … the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
S-8
USE
8-K
EX-99.1
rep6x7r8i0m5ue13
26 Feb 24
Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress
4:04pm
8-K
EX-99.1
g8y jt179us
9 Jan 24
Results of Operations and Financial Condition
2:15pm
8-K
EX-99.1
6o289zkie d0g8x
6 Nov 23
Revolution Medicines Reports Third Quarter 2023 Financial Results and Update on Corporate Progress
4:05pm
DEFA14A
zjxe0r2fiwmke t781x
1 Nov 23
Additional proxy soliciting materials
7:15am
425
x2tg06m36b
1 Nov 23
Business combination disclosure
7:11am
8-K
EX-99.1
dtcs34emax4dhi1g d18
1 Nov 23
Revolution Medicines Also Announces the Final Exchange Ratio of 0.1112
7:08am
8-K
od33aolb3xxku9
1 Nov 23
Revolution Medicines Also Announces the Final Exchange Ratio of 0.1112
7:08am
425
rt39w
23 Oct 23
Business combination disclosure
6:13am
8-K
EX-99.1
lnxko8mg
23 Oct 23
Regulation FD Disclosure
6:11am
8-K
ylu c7d49xpr
23 Oct 23
Regulation FD Disclosure
6:11am
8-K
xno6fvww
13 Oct 23
Other Events
11:54am
DEFM14A
tsgoxp
29 Sep 23
Proxy related to merger
4:19pm
424B3
srg01xoorns
29 Sep 23
Prospectus supplement
4:17pm
S-4/A
1zr2pxo
27 Sep 23
Registration of securities issued in business combination transactions (amended)
5:25pm